Tenax Therapeutics IncKapitalflussrechnung
| Preis (2026-07-28) | 52W Hoch | 52W Tief |
| 15.8 USD | 19,4 USD | 5,78 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 35,222 USD | 3 | 1 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 26.525.159 | 7,81 | 1,38 |
Kennzahl in 1000 USD | TTM 2024-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2001-12-31 | 2000-12-31 | 1999-12-31 | 1998-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cashflow aus operativer Geschäftstätigkeit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
▸ Operative Cashflow Marge | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% |
Investitionsausgaben (CapEx) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cashflow aus Investitionstätigkeit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cashflow aus Finanzierungstätigkeit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Freier Cashflow | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
▸ Freie Cashflow Marge | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% |
Ausgeschüttete Dividenden | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Neuausgabe und Rückkäufe von Stammaktien | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |